These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 12693314)

  • 1. [Pathophysiology of inflammatory bowel disease].
    Lehmann FS
    Ther Umsch; 2003 Mar; 60(3):127-32. PubMed ID: 12693314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease.
    Sartor RB
    Gastroenterol Clin North Am; 1995 Sep; 24(3):475-507. PubMed ID: 8809232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of genetic, environmental and immune factors in the pathogenesis of inflammatory bowel diseases.
    Chowers Y
    Isr Med Assoc J; 2002 Oct; 4(10):815-7. PubMed ID: 12389349
    [No Abstract]   [Full Text] [Related]  

  • 4. The epidemiology and the pathogenesis of inflammatory bowel disease.
    Karlinger K; Györke T; Makö E; Mester A; Tarján Z
    Eur J Radiol; 2000 Sep; 35(3):154-67. PubMed ID: 11000558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease.
    Sýkora J; Subrt I; Dìdek P; Siala K; Schwarz J; Machalová V; Varvarovská J; Pazdiora P; Pozler O; Stozický F
    J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TLR4 D299G polymorphism modulates cytokine expression in ulcerative colitis.
    Meena NK; Verma R; Verma N; Ahuja V; Paul J
    J Clin Gastroenterol; 2013 Oct; 47(9):773-80. PubMed ID: 23470644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Family and twin studies in inflammatory bowel disease.
    Halme L; Paavola-Sakki P; Turunen U; Lappalainen M; Farkkila M; Kontula K
    World J Gastroenterol; 2006 Jun; 12(23):3668-72. PubMed ID: 16773682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights into the immunopathology of chronic inflammatory bowel disease.
    Ehrhardt RO
    Semin Gastrointest Dis; 1996 Jul; 7(3):144-50. PubMed ID: 8817766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory bowel disease: progress and current concepts of etiopathogenesis.
    Scaldaferri F; Fiocchi C
    J Dig Dis; 2007 Nov; 8(4):171-8. PubMed ID: 17970872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent understanding of IBD pathogenesis: implications for future therapies.
    Kucharzik T; Maaser C; Lügering A; Kagnoff M; Mayer L; Targan S; Domschke W
    Inflamm Bowel Dis; 2006 Nov; 12(11):1068-83. PubMed ID: 17075348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms and efficacy of immunobiologic therapies for inflammatory bowel diseases.
    Ghosh N; Chaki R; Mandal V; Lin GD; Mandal SC
    Int Rev Immunol; 2010; 29(1):4-37. PubMed ID: 20100080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory bowel disease: a complex group of genetic disorders.
    Hugot JP
    Best Pract Res Clin Gastroenterol; 2004 Jun; 18(3):451-62. PubMed ID: 15157820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology and natural history of inflammatory bowel diseases.
    Cosnes J; Gower-Rousseau C; Seksik P; Cortot A
    Gastroenterology; 2011 May; 140(6):1785-94. PubMed ID: 21530745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etiology and pathogenesis of inflammatory bowel disease.
    Schmidt C; Stallmach A
    Minerva Gastroenterol Dietol; 2005 Jun; 51(2):127-45. PubMed ID: 15990703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inflammatory bowel diseases: an immunological approach].
    Sepúlveda SE; Beltrán CJ; Peralta A; Rivas P; Rojas N; Figueroa C; Quera R; Hermoso MA
    Rev Med Chil; 2008 Mar; 136(3):367-75. PubMed ID: 18575665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of haptoglobin polymorphisms and deficiency on susceptibility to inflammatory bowel disease and on severity of murine colitis.
    Márquez L; Shen C; Cleynen I; De Hertogh G; Van Steen K; Machiels K; Perrier C; Ballet V; Organe S; Ferrante M; Henckaerts L; Galicia G; Rutgeerts P; Ceuppens JL; Vermeire S
    Gut; 2012 Apr; 61(4):528-34. PubMed ID: 21708824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease.
    Cantor MJ; Nickerson P; Bernstein CN
    Am J Gastroenterol; 2005 May; 100(5):1134-42. PubMed ID: 15842590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features in familial cases of Crohn's disease and ulcerative colitis in Italy: a GISC study. Italian Study Group for the Disease of Colon and Rectum.
    Annese V; Andreoli A; Astegiano M; Campieri M; Caprilli R; Cucchiara S; D'Incà R; Giaccari S; Iaquinto G; Lombardi G; Napolitano G; Pera A; Riegler G; Valpiani D; Andriulli A;
    Am J Gastroenterol; 2001 Oct; 96(10):2939-45. PubMed ID: 11693330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbial-host interactions in inflammatory bowel diseases and experimental colitis.
    Sartor RB
    Nestle Nutr Workshop Ser Pediatr Program; 2009; 64():121-32; discussion 132-7, 251-7. PubMed ID: 19710519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of ulcerative colitis and Crohn's disease with monoclonal antibody].
    Asakura H
    Nihon Rinsho; 2002 Mar; 60(3):531-8. PubMed ID: 11904969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.